Filter
961
Text search:
European
Medicines
Agency
Featured
Recommendations
100
New Publications
212
Language
Document type
No document type
424
Studies & Reports
226
Guidelines
154
Manuals
56
Strategic & Response Plan
43
Fact sheets
29
Situation Updates
15
Training Material
9
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
Western and Central Europe
60
Global
46
Ukraine
38
Eastern Europe
25
Africa
22
Sierra Leone
20
Nigeria
18
Liberia
16
Ghana
16
Kenya
16
Nepal
14
Ethiopia
12
Myanmar / Burma
12
Zambia
11
Syria
10
Latin America and the Carribbean
10
India
9
Germany
9
Eastern Europe and Central Asia
9
Guinea
8
Uganda
8
Philippines
8
Rwanda
8
South Africa
8
Bangladesh
8
Moldova
8
Congo, Democratic Republic of
7
West and Central Africa
7
Zimbabwe
6
Thailand
6
Indonesia
6
Burkina Faso
5
South Sudan
5
Tanzania
5
Malawi
5
East and Southern Africa
5
South–East Asia Region
5
Russia
5
Senegal
4
Jordan
4
Namibia
4
Brazil
4
Hungary
4
Botswana
4
Middle East and North Africa
4
Asia
4
Venezuela
4
Poland
4
Georgia
4
Pakistan
3
Cambodia
3
North Macedonia
3
Yemen
3
Albania
3
Romania
3
Jamaica
3
Morocco
2
Afghanistan
2
Lebanon
2
Mozambique
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Serbia
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Bulgaria
2
Iran
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Turkey
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Mongolia
1
Slovakia
1
Kyrgyzstan
1
Australia
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
259
Clinical Guidelines
111
Public Health
57
Women & Child Health
41
Key Resources
28
Pharmacy & Technologies
23
Capacity Building
9
Toolboxes
AMR
90
COVID-19
89
TB
84
HIV
79
Mental Health
66
Pharmacy
53
Conflict
45
Rapid Response
32
Planetary Health
31
Ebola
27
Global Health Education
26
Refugee
23
Disability
18
NCDs
18
Health Financing Toolbox
15
Caregiver
14
NTDs
13
Natural Hazards
9
Zika
7
Specific Hazards
5
Polio
4
Cholera
2
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Towards ending tuberculosis and multidrug-resistant tuberculosis.
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv
...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
A stated objective of WHO’s European Mental Health Action Plan 2013–2020 is to ensure better information and knowledge for service planning, development, monitoring and evaluation, including requesting Member States to report on the indicato
...
An update from the EU Early Warning System
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Accessed November 2017
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Meeting report, 25-26 September 2017 Copenhagen, Denmark
